Neeves et al., 2008 - Google Patents
Microfluidic focal thrombosis model for measuring murine platelet deposition and stability: PAR4 signaling enhances shear‐resistance of platelet aggregatesNeeves et al., 2008
View HTML- Document ID
- 279852249264410174
- Author
- Neeves K
- Maloney S
- Fong K
- Schmaier A
- Kahn M
- Brass L
- Diamond S
- Publication year
- Publication venue
- Journal of Thrombosis and Haemostasis
External Links
Snippet
Background: Flow chambers allow the ex vivo study of platelet response to defined surfaces at controlled wall shear stresses. However, most assays require 1–10 mL of blood and are poorly suited for murine whole blood experiments. Objective: To measure murine platelet …
- 210000001772 Blood Platelets 0 title abstract description 121
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Neeves et al. | Microfluidic focal thrombosis model for measuring murine platelet deposition and stability: PAR4 signaling enhances shear‐resistance of platelet aggregates | |
US10908171B2 (en) | Additive channels | |
Menon et al. | Micro-engineered perfusable 3D vasculatures for cardiovascular diseases | |
Westein et al. | Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner | |
Young et al. | Macro-and microscale fluid flow systems for endothelial cell biology | |
Ruggeri et al. | Activation-independent platelet adhesion and aggregation under elevated shear stress | |
Noris et al. | Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions | |
Song et al. | Anastomosis of endothelial sprouts forms new vessels in a tissue analogue of angiogenesis | |
Zhang et al. | Application of microfluidic devices in studies of thrombosis and hemostasis | |
Conant et al. | Well plate microfluidic system for investigation of dynamic platelet behavior under variable shear loads | |
Siren et al. | An improved in vitro model for studying the structural and functional properties of the endothelial glycocalyx in arteries, capillaries and veins | |
Van Aelst et al. | Microfluidic flow chambers using reconstituted blood to model hemostasis and platelet transfusion in vitro | |
Szydzik et al. | Active micropump-mixer for rapid antiplatelet drug screening in whole blood | |
Deng et al. | Understanding stenosis-induced platelet aggregation on a chip by high-speed optical imaging | |
Shirure et al. | Mitigating neutrophil trafficking and cardiotoxicity with DS–IkL in a microphysiological system of a cytokine storm | |
de Groot et al. | Perfusion chambers | |
Major et al. | Inner surface modification of the tube-like elements for medical applications | |
Nezafati | Analyzing biomaterial surfaces and blood-surface interactions | |
Owens et al. | Ethanol inhibition of thrombus formation on collagen-coated glass | |
RU2727753C1 (en) | Method of determining degree of hydrodynamic activation of von willebrand factor and device for its implementation | |
Sperling et al. | Advanced in vitro hemocompatibility assessment of biomaterials using a new flow incubation system | |
Kaneko et al. | Mechanisms of platelet retention in the collagen-coated–bead column | |
Chang | Application of Microfluidic Technology for Studying the Effects of Fluid Forces and Extracellular Matrix on Angiogenesis and Lymphangiogenesis | |
de Groot | Shear induced platelet activation | |
Zhang | The structural features regulate Von Willebrand factor function in vitro and in vivo |